Segmentation of key figures (Details 8) - USD ($)
$ in Millions |
3 Months Ended |
6 Months Ended |
Jun. 30, 2020 |
Jun. 30, 2019 |
Jun. 30, 2020 |
Jun. 30, 2019 |
| Disclosure of operating segments [line items] |
|
|
|
|
| Net sales to third parties from continuing operations |
$ 11,347
|
$ 11,764
|
$ 23,630
|
$ 22,870
|
| Change over period [member] |
|
|
|
|
| Disclosure of operating segments [line items] |
|
|
|
|
| Net sales, change in % |
(4.00%)
|
|
3.00%
|
|
| Net sales, change in %, cc |
(1.00%)
|
|
6.00%
|
|
| Sandoz [member] |
|
|
|
|
| Disclosure of operating segments [line items] |
|
|
|
|
| Net sales to third parties from continuing operations |
$ 2,159
|
2,438
|
$ 4,687
|
4,764
|
| Sandoz [member] | Change over period [member] |
|
|
|
|
| Disclosure of operating segments [line items] |
|
|
|
|
| Net sales, change in % |
(11.00%)
|
|
(2.00%)
|
|
| Net sales, change in %, cc |
(9.00%)
|
|
1.00%
|
|
| Sandoz [member] | Retail Generics [member] |
|
|
|
|
| Disclosure of operating segments [line items] |
|
|
|
|
| Net sales to third parties from continuing operations |
$ 1,576
|
1,903
|
$ 3,545
|
3,753
|
| Sandoz [member] | Retail Generics [member] | Change over period [member] |
|
|
|
|
| Disclosure of operating segments [line items] |
|
|
|
|
| Net sales, change in % |
(17.00%)
|
|
(6.00%)
|
|
| Net sales, change in %, cc |
(14.00%)
|
|
(3.00%)
|
|
| Sandoz [member] | Biopharmaceuticals [member] |
|
|
|
|
| Disclosure of operating segments [line items] |
|
|
|
|
| Net sales to third parties from continuing operations |
$ 466
|
401
|
$ 916
|
752
|
| Sandoz [member] | Biopharmaceuticals [member] | Change over period [member] |
|
|
|
|
| Disclosure of operating segments [line items] |
|
|
|
|
| Net sales, change in % |
16.00%
|
|
22.00%
|
|
| Net sales, change in %, cc |
19.00%
|
|
25.00%
|
|
| Sandoz [member] | Anti Infectives [member] |
|
|
|
|
| Disclosure of operating segments [line items] |
|
|
|
|
| Net sales to third parties from continuing operations |
$ 117
|
134
|
$ 226
|
259
|
| Sandoz [member] | Anti Infectives [member] | Change over period [member] |
|
|
|
|
| Disclosure of operating segments [line items] |
|
|
|
|
| Net sales, change in % |
(13.00%)
|
|
(13.00%)
|
|
| Net sales, change in %, cc |
(12.00%)
|
|
(11.00%)
|
|
| Sandoz [member] | Anti Infectives [member] | Anti Infectives sold under Sandoz name [member] |
|
|
|
|
| Disclosure of operating segments [line items] |
|
|
|
|
| Net sales to third parties from continuing operations |
$ 134
|
$ 186
|
$ 356
|
$ 390
|